DK1066056T4 - Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernmangel, fremgangsmåde til fremstilling af jerndextranforbindelsen og anvendelse af denne forbindelse til fremstilling af et... - Google Patents

Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernmangel, fremgangsmåde til fremstilling af jerndextranforbindelsen og anvendelse af denne forbindelse til fremstilling af et...

Info

Publication number: DK1066056T4
Authority: DK; Denmark
Prior art keywords: compound; iron; iron dextran; prevention; preparing
Prior art date: 1998-03-25

Application number

DK99908785T

Other languages

English (en)

Other versions

DK1066056T3 (da

Inventor

Lars Christensen

Hans Berg Andreasen

Original Assignee

Pharmacosmos Holding As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-03-25

Filing date

1999-03-24

Publication date

2009-04-14

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8093321&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1066056(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-03-24 Application filed by Pharmacosmos Holding As filed Critical Pharmacosmos Holding As

2002-10-14 Application granted granted Critical

2002-10-14 Publication of DK1066056T3 publication Critical patent/DK1066056T3/da

2009-04-14 Publication of DK1066056T4 publication Critical patent/DK1066056T4/da

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Hematology (AREA)
Diabetes (AREA)
Nutrition Science (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)

DK99908785T 1998-03-25 1999-03-24 Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernmangel, fremgangsmåde til fremstilling af jerndextranforbindelsen og anvendelse af denne forbindelse til fremstilling af et... DK1066056T4 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DK199800420A DK172860B1 (da)	1998-03-25	1998-03-25	Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman
PCT/DK1999/000160 WO1999048533A1 (en)	1998-03-25	1999-03-24	An iron-dextran compound for use as a component in a therapeutical composition for prophylaxis or treatment of iron-deficiency, a process for producing said iron-dextran compound and use of said compound for the preparation of a parenterally administrable therapeutical composition

Publications (2)

Publication Number	Publication Date
DK1066056T3 DK1066056T3 (da)	2002-10-14
DK1066056T4 true DK1066056T4 (da)	2009-04-14

Family

ID=8093321

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK199800420A DK172860B1 (da)	1998-03-25	1998-03-25	Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman
DK99908785T DK1066056T4 (da)	1998-03-25	1999-03-24	Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernmangel, fremgangsmåde til fremstilling af jerndextranforbindelsen og anvendelse af denne forbindelse til fremstilling af et...

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK199800420A DK172860B1 (da)	1998-03-25	1998-03-25	Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman

Country Status (28)

Country	Link
US (1)	US6291440B1 (da)
EP (1)	EP1066056B2 (da)
JP (1)	JP4558198B2 (da)
KR (1)	KR100612071B1 (da)
CN (1)	CN1147322C (da)
AR (1)	AR015738A1 (da)
AT (1)	ATE220560T1 (da)
AU (1)	AU740432B2 (da)
BR (1)	BRPI9908914B8 (da)
CA (1)	CA2322633C (da)
CZ (1)	CZ300823B6 (da)
DE (1)	DE69902154T3 (da)
DK (2)	DK172860B1 (da)
EA (1)	EA003427B1 (da)
ES (1)	ES2180279T5 (da)
HK (1)	HK1033426A1 (da)
HU (1)	HU228483B1 (da)
ID (1)	ID26778A (da)
NO (1)	NO329591B1 (da)
NZ (1)	NZ505983A (da)
PL (1)	PL195582B1 (da)
PT (1)	PT1066056E (da)
SI (1)	SI1066056T2 (da)
SK (1)	SK284499B6 (da)
TR (1)	TR200002733T2 (da)
UA (1)	UA70939C2 (da)
WO (1)	WO1999048533A1 (da)
ZA (1)	ZA200004016B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK173138B1 (da) *	1998-11-20	2000-02-07	Pharmacosmos Holding As	Fremgangsmåde til fremstilling af en jerndextranforbindelse, jerndextranforbindelse fremstillet efter fremgangsmåden, farma
US7871597B2 (en)	1999-04-09	2011-01-18	Amag Pharmaceuticals, Inc.	Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents
WO2000061191A2 (en) *	1999-04-09	2000-10-19	Advanced Magnetics, Inc.	Heat stable coated colloidal iron oxides
KR20020003344A (ko) *	2001-12-17	2002-01-12	유형선	철분 보급제 경구 투여 제제 조성물
NZ535761A (en) *	2002-04-09	2007-09-28	Pharmacosmos Holding As	Iron dextrin compounds for the treatment of iron deficiency anaemia
DE10249552A1 (de)	2002-10-23	2004-05-13	Vifor (International) Ag	Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
US20060116349A1 (en) *	2003-03-14	2006-06-01	Luitpold Pharmaceuticals, Inc.	Methods and compositions for administration of iron for the treatment of restless leg syndrome
DE102004031181A1 (de) *	2004-06-28	2006-01-19	Vifor (International) Ag	Phosphatadsorbens
ITMO20050056A1 (it) *	2005-03-15	2006-09-16	Biofer Spa	Processo per la preparazione di complessi del ferro trivalente con zuccheri mono-, di- e polisaccaridi.
EP1757299A1 (de)	2005-08-25	2007-02-28	Vifor (International) Ag	Eisen(III)-Komplexverbindungen zur Behandlung von Eisenmangel-Zuständen bei Patienten mit chronisch-entzündlicher Darmerkrankung
CA2635894C (en)	2006-01-06	2017-09-12	Luitpold Pharmaceuticals, Inc.	Methods and compositions for administration of iron
EP1947120A1 (de) *	2007-01-19	2008-07-23	Vifor (International) Ag	Eisen-Kohlenhydrat-Komplex-Verbindungen
EP1997833A1 (de) *	2007-05-29	2008-12-03	Vifor (International) Ag	Wasserlösliche Eisen-Kohlenhydratderivat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
CN101585887B (zh) *	2008-05-22	2011-12-14	中国科学院过程工程研究所	应用纳滤技术对右旋糖酐铁络合物水溶液进行脱盐和浓缩的方法
CA2756580A1 (en) *	2009-03-25	2010-09-30	Hans Andreasen	A stable iron oligosaccharide compound
CN101967205B (zh) *	2010-10-12	2013-04-17	滨州学院	一种β-葡聚糖铁复合物及其制备方法
EP2537866A1 (en)	2011-06-21	2012-12-26	Serumwerk Bernburg AG	Hydroxyethyl starch derivatives, method for manufacturing the same and therapeutical uses thereof
PL398814A1 (pl)	2012-04-16	2013-10-28	Uniwersytet Jagiellonski	Zastosowanie pochodnych dekstranu do przeciwdzialania lub leczenia niedokrwistosci
US10172882B2 (en)	2014-06-22	2019-01-08	Dexcel Pharma Technologies Ltd.	Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
US11040059B2 (en) *	2014-10-27	2021-06-22	Pharmacosmos Holding A/S	Treatment or prevention of anaemia in pregnant non-human mammals
KR20200044030A (ko) *	2017-09-11	2020-04-28	파르마코스모스 홀딩 에이/에스	치료용 철 착화합물
CN109646454A (zh) *	2018-12-29	2019-04-19	博瑞生物医药（苏州）股份有限公司	异麦芽糖酐铁1000的制备方法
CN110183548B (zh) *	2019-06-28	2021-05-18	瑞普（天津）生物药业有限公司	一种低分子葡聚糖铁的制备方法及其应用
AU2022323733A1 (en)	2021-08-03	2024-02-29	Pharmacosmos Holding A/S	Iron complex compounds for subcutaneous use in therapy of iron deficiency in companion animals

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
USRE24642E (en)		1959-04-28		Therapeutic preparations of iron
DK117730A (da)
US2885393A (en)	1956-02-24	1959-05-05	R K Laros Company	Dextran-iron complex and process for making same
US3093545A (en)	1960-08-29	1963-06-11	Armour Pharma	Therapeutic iron-dextran preparations
US3234209A (en) *	1963-09-13	1966-02-08	Chemicals Inc	Process for making iron hydrogenated dextran
DE1293144B (de) *	1964-11-04	1969-04-24	Hausmann Ag Labor	Verfahren zur Herstellung von Komplexverbindungen des Eisens mit Sorbit, Gluconsaeure und einem Oligosaccharid
GB1183940A (en)	1966-10-22	1970-03-11	Fisons Pharmaceuticals Ltd	Ferric Hydroxide Complexes
GB1200902A (en)	1967-05-13	1970-08-05	Fisons Pharmaceuticals Ltd	Iron-dextran complexes
CH507993A (de)	1967-07-13	1971-05-31	Kutnowskie Zakl Farma	Verfahren zur Herstellung von Eisen(III)-komplexverbindungen mit hydriertem Dextran
DK129353B (da)	1968-04-29	1974-09-30	Fisons Pharmaceuticals Ltd	Analogifremgangsmåde til fremstilling af et ferrihydroxid-dextranderivatkompleks eller en opløsning deraf.
US3697502A (en)	1969-11-03	1972-10-10	Christensen Henry M	Method of making iron dextran-preparations
GB1562913A (en) *	1976-06-16	1980-03-19	Fisons Ltd	Fractionating fluid mixtures of dextrans
DE3422249A1 (de) *	1984-06-15	1985-12-19	Pfeifer & Langen, 5000 Köln	Wasserloesliches eisendextran und verfahren zu seiner herstellung
US5102652A (en) *	1986-07-03	1992-04-07	Advanced Magnetics Inc.	Low molecular weight carbohydrates as additives to stabilize metal oxide compositions
US4827945A (en)	1986-07-03	1989-05-09	Advanced Magnetics, Incorporated	Biologically degradable superparamagnetic materials for use in clinical applications
IT1263831B (it) *	1993-01-29	1996-09-04	Paolo Chiesi	Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo basico, un acido ed una ciclodestrina
RU2093577C1 (ru) *	1993-11-04	1997-10-20	Государственный институт кровезаменителей и медицинских препаратов	Способ получения декстрана
GB9402029D0 (en) *	1994-02-03	1994-03-30	Smithkline Beecham Plc	Novel formulation
US5624668A (en) *	1995-09-29	1997-04-29	Luitpold Pharmaceuticals, Inc.	Iron dextran formulations

1998
- 1998-03-25 DK DK199800420A patent/DK172860B1/da not_active IP Right Cessation
1999
- 1999-03-24 EA EA200000981A patent/EA003427B1/ru not_active IP Right Cessation
- 1999-03-24 HU HU0101189A patent/HU228483B1/hu unknown
- 1999-03-24 AR ARP990101309A patent/AR015738A1/es active IP Right Grant
- 1999-03-24 CZ CZ20003535A patent/CZ300823B6/cs not_active IP Right Cessation
- 1999-03-24 JP JP2000537579A patent/JP4558198B2/ja not_active Expired - Lifetime
- 1999-03-24 SI SI9930103T patent/SI1066056T2/sl unknown
- 1999-03-24 PT PT99908785T patent/PT1066056E/pt unknown
- 1999-03-24 WO PCT/DK1999/000160 patent/WO1999048533A1/en active IP Right Grant
- 1999-03-24 CA CA002322633A patent/CA2322633C/en not_active Expired - Fee Related
- 1999-03-24 AT AT99908785T patent/ATE220560T1/de active
- 1999-03-24 CN CNB998042498A patent/CN1147322C/zh not_active Expired - Lifetime
- 1999-03-24 SK SK1409-2000A patent/SK284499B6/sk not_active IP Right Cessation
- 1999-03-24 AU AU28273/99A patent/AU740432B2/en not_active Ceased
- 1999-03-24 DK DK99908785T patent/DK1066056T4/da active
- 1999-03-24 PL PL99343164A patent/PL195582B1/pl unknown
- 1999-03-24 UA UA2000095459A patent/UA70939C2/uk unknown
- 1999-03-24 NZ NZ505983A patent/NZ505983A/xx not_active IP Right Cessation
- 1999-03-24 KR KR1020007010563A patent/KR100612071B1/ko not_active IP Right Cessation
- 1999-03-24 EP EP99908785A patent/EP1066056B2/en not_active Expired - Lifetime
- 1999-03-24 TR TR2000/02733T patent/TR200002733T2/xx unknown
- 1999-03-24 BR BRPI9908914 patent/BRPI9908914B8/pt not_active IP Right Cessation
- 1999-03-24 US US09/509,454 patent/US6291440B1/en not_active Expired - Lifetime
- 1999-03-24 ES ES99908785T patent/ES2180279T5/es not_active Expired - Lifetime
- 1999-03-24 ID IDW20001881A patent/ID26778A/id unknown
- 1999-03-24 DE DE69902154T patent/DE69902154T3/de not_active Expired - Lifetime
2000
- 2000-08-07 ZA ZA200004016A patent/ZA200004016B/xx unknown
- 2000-08-18 NO NO20004151A patent/NO329591B1/no not_active IP Right Cessation
2001
- 2001-06-13 HK HK01104034A patent/HK1033426A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
EA200000981A1 (ru)	2001-02-26
NO329591B1 (no)	2010-11-15
HK1033426A1 (en)	2001-08-31
EP1066056A1 (en)	2001-01-10
JP4558198B2 (ja)	2010-10-06
PL343164A1 (en)	2001-07-30
ES2180279T5 (es)	2009-05-05
TR200002733T2 (tr)	2000-12-21
PL195582B1 (pl)	2007-10-31
KR100612071B1 (ko)	2006-08-11
DE69902154D1 (de)	2002-08-22
AR015738A1 (es)	2001-05-16
ZA200004016B (en)	2001-07-25
DE69902154T3 (de)	2009-07-09
CA2322633A1 (en)	1999-09-30
ID26778A (id)	2001-02-08
AU740432B2 (en)	2001-11-01
BRPI9908914B1 (pt)	2012-06-12
EP1066056B1 (en)	2002-07-17
EP1066056B2 (en)	2008-12-10
SI1066056T1 (en)	2002-12-31
NO20004151L (no)	2000-08-18
PT1066056E (pt)	2002-12-31
BRPI9908914A (pt)	2000-11-21
DK172860B1 (da)	1999-08-16
AU2827399A (en)	1999-10-18
CA2322633C (en)	2009-01-27
HUP0101189A2 (hu)	2001-08-28
UA70939C2 (uk)	2004-11-15
CN1293577A (zh)	2001-05-02
HU228483B1 (en)	2013-03-28
DK42099A (da)	1999-08-16
SK14092000A3 (sk)	2001-04-09
DE69902154T2 (de)	2003-03-06
EA003427B1 (ru)	2003-04-24
HUP0101189A3 (en)	2003-12-29
JP2002507582A (ja)	2002-03-12
US6291440B1 (en)	2001-09-18
KR20010034641A (ko)	2001-04-25
BRPI9908914B8 (pt)	2021-07-06
NZ505983A (en)	2002-11-26
CN1147322C (zh)	2004-04-28
SI1066056T2 (sl)	2009-04-30
CZ20003535A3 (cs)	2001-04-11
ATE220560T1 (de)	2002-08-15
ES2180279T3 (es)	2003-02-01
CZ300823B6 (cs)	2009-08-19
NO20004151D0 (no)	2000-08-18
SK284499B6 (sk)	2005-05-05
DK1066056T3 (da)	2002-10-14
WO1999048533A1 (en)	1999-09-30

Publication	Publication Date	Title
DK1066056T4 (da)	2009-04-14	Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernmangel, fremgangsmåde til fremstilling af jerndextranforbindelsen og anvendelse af denne forbindelse til fremstilling af et...
ATE364386T1 (de)	2007-07-15	(s,s)-reboxetine zur behandlung von chronischen erschöpfungssyndrom
DK1052905T3 (da)	2004-06-28	Kimhæmmende fremgangsmåde til rodknolde og lög med anvendelse af eugenol og/eller isoeugenol
MXPA03006724A (es)	2003-10-24	Combinaciones de inhibidor(es) de absorcion de esterol con agente(s) cardiovascular(es) para el tratamiento de condiciones vasculares.
TR199802676A3 (tr)	1999-11-22	Tümörlerin, tümörle ilgili hastaliklarin ve kaseksinin tedavisi ve önlenmesi için yöntem.
DK1427437T3 (da)	2013-03-04	Oxyntomodulin til forebyggelse eller behandling af overvægt
ZA993364B (en)	2000-12-01	Novel 4-phenylpiperidines for the treatment of pruritic dermatoses.
ZA991489B (en)	1999-09-30	Oxaliplatin solution formulations and the method of use thereof.
NO990722D0 (no)	1999-02-16	FremgangsmÕte for behandling av hjertesvikt
PT1300084E (pt)	2006-06-30	Composicaio para o tratamento de insuficiencias venosas cronicas melha.
IS2296B (is)	2007-10-15	Aðferð til framleiðslu á vernduðu 4-amínómetýl-pýrrólidín-3-óni.
HK1064261A1 (en)	2005-01-28	Method for the treatment of tobacco.
HK1041827A1 (en)	2002-07-26	Compounds for the treatment of estrogen-defendent illnesses and methods for making and using the dame.
ZA200003236B (en)	2002-01-02	Combination therapy for the treatment of migraine.
MXPA02012907A (es)	2003-09-22	Procedimiento para encontrar compuestos que son adecuados para el tratamiento y/o la profilaxia de la obesidad.
AP2004003070A0 (en)	2004-06-30	The method of treating cancer.
ZA200004865B (en)	2001-03-12	Heat transpiration preparation and method of the heat transpiration of chemical by using the same.
WO2000000634A3 (en)	2000-04-13	METHODS OF INHIBITING $i(HELICOBACTER PYLORI)
MXPA03004017A (es)	2004-02-12	Metodo para el tratamiento de inflamacion.
ITMI991605A0 (it)	1999-07-21	Follatore per il trattamento di cuoio pelli e simili
WO2003017817A3 (en)	2004-04-08	Diagnosis, prevention and treatment of cancer
WO2002062205A3 (en)	2003-09-12	Methods for diagnosing and treating heart disease
NO20003481D0 (no)	2000-07-06	FremgangsmÕte for behandling av COPD
DK1152760T3 (da)	2007-07-30	Anvendelse af 4-aminopyridin til behandling af perifere neuropatier
DK1390364T3 (da)	2004-12-20	Aryl-8-azabicyclo[3.2.1]octaner til behandling af depression